Cytomedix to Host Third Quarter 2010 Financial Results Conference Call on Thursday, November 11, 2010
02. November 2010 08:59 ET
|
Cytomedix, Inc.
GAITHERSBURG, Md., Nov. 2, 2010 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (NYSE Amex:GTF), a leading developer of biologically active regenerative therapies for wound care, inflammation and angiogenesis,...
Cytomedix to Showcase AutoloGel System at the 18th Annual Scientific Meeting of the International Society of Hair Restoration Surgery
20. Oktober 2010 08:15 ET
|
Cytomedix, Inc.
GAITHERSBURG, Md., Oct. 20, 2010 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (NYSE Amex:GTF), a leading developer of biologically active regenerative therapies for wound care, inflammation and angiogenesis,...
Cytomedix Secures $13 Million in Committed Funding
08. Oktober 2010 08:30 ET
|
Cytomedix, Inc.
GAITHERSBURG, Md., Oct. 8, 2010 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (NYSE Amex:GTF), a leading developer of biologically active regenerative therapies for wound care, inflammation and angiogenesis,...
Cytomedix Announces AutoloGel System Oral Presentation at the Academy of Spinal Cord Injury Professionals' Annual Meeting
23. September 2010 09:13 ET
|
Cytomedix, Inc.
ROCKVILLE, Md., Sept. 23, 2010 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (NYSE Amex:GTF), a leading developer of biologically active regenerative therapies for wound care, inflammation and angiogenesis,...
Cytomedix Announces AutoloGel System Poster Presentation at the Symposium on Advanced Wound Care (SAWC) Fall 2010
23. September 2010 09:04 ET
|
Cytomedix, Inc.
ROCKVILLE, Md., Sept. 23, 2010 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (NYSE Amex:GTF), a leading developer of biologically active regenerative therapies for wound care, inflammation and angiogenesis,...
Cytomedix to Present at Rodman & Renshaw 12th Annual Global Investment Conference
07. September 2010 08:00 ET
|
Cytomedix, Inc.
ROCKVILLE, Md., Sept. 7, 2010 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (NYSE Amex:GTF) (the "Company"), a leading developer of biologically active regenerative therapies for wound care, inflammation and...
Cytomedix Reports Second Quarter 2010 Financial Results
16. August 2010 17:27 ET
|
Cytomedix, Inc.
ROCKVILLE, Md., Aug. 16, 2010 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (NYSE Amex:GTF) (the "Company"), a leading developer of biologically active regenerative therapies for wound care, inflammation and...
Cytomedix to Host Second Quarter 2010 Financial Results Conference Call on Tuesday, August 17, 2010
09. August 2010 10:05 ET
|
Cytomedix, Inc.
ROCKVILLE, Md., Aug. 9, 2010 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (NYSE Amex:GTF), a leading developer of biologically active regenerative therapies for wound care, inflammation and angiogenesis, today...
Cytomedix Appoints Patrick Vanek as Vice President of Operations
28. Juli 2010 10:47 ET
|
Cytomedix, Inc.
ROCKVILLE, Md., July 28, 2010 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (NYSE Amex:GTF), a leading developer of biologically active regenerative therapies for wound care, inflammation and angiogenesis,...
Positive Data From Study of the AutoloGel System to Treat Complex Chronic Wounds Published in Ostomy Wound Management
16. Juni 2010 09:23 ET
|
Cytomedix, Inc.
ROCKVILLE, Md., June 16, 2010 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (NYSE Amex:GTF), a leading developer of biologically active regenerative therapies for wound care, inflammation and angiogenesis,...